Characterization of Patients With Borderline Pulmonary Arterial Pressure

Chest

Volumn 146, Issue 6, 2014, Pages 1486-1493

  Kovacs, Gabor ^a   Avian, Alexander ^a   Tscherner, Maria ^a   Foris, Vasile ^a   Bachmaier, Gerhard ^a   Olschewski, Andrea ^a   Olschewski, Horst ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

6 MINUTE WALK DISTANCE; ADULT; AGE; AGED; ARTICLE; ASTHMA; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART FAILURE; HEART OUTPUT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LUNG ARTERY PRESSURE; LUNG CANCER; LUNG FIBROSIS; LUNG FUNCTION; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESTING MEAN PULMONARY ARTERY PRESSURE; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; WALKING SPEED; ARTERIAL PRESSURE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMPARATIVE STUDY; EXERCISE TOLERANCE; HEMODYNAMICS; HYPERTENSION, PULMONARY; LUNG WEDGE PRESSURE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SURVIVAL RATE; VASCULAR RESISTANCE;

ADULT; AGE FACTORS; AGED; ARTERIAL PRESSURE; CARDIAC CATHETERIZATION; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY WEDGE PRESSURE; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; VASCULAR RESISTANCE;

EID: 84925286021     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0194     Document Type: Article

References (19)

1. 1 Galiè, N, Hoeper, MM, Humbert, M, et al. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:6 (2009), 1219–1263.
2. 2 Tolle, JJ, Waxman, AB, Van Horn, TL, Pappagianopoulos, PP, Systrom, DM, Exercise-induced pulmonary arterial hypertension. Circulation 118:21 (2008), 2183–2189.
3. 3 Condliffe, R, Kiely, DG, Peacock, AJ, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179:2 (2009), 151–157.
4. 4 Saggar, R, Khanna, D, Furst, DE, et al. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum 62:12 (2010), 3741–3750.
5. 5 Valerio, CJ, Schreiber, BE, Handler, CE, Denton, CP, Coghlan, JG, Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum 65:4 (2013), 1074–1084.
6. 6 Kovacs, G, Maier, R, Aberer, E, et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 180:9 (2009), 881–886.
7. 7 Whyte, K, Hoette, S, Herve, P, et al. The association between resting and mild-to-moderate exercise pulmonary artery pressure. Eur Respir J 39:2 (2012), 313–318.
8. 8 Kovacs, G, Maier, R, Aberer, E, et al. Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum 64:4 (2012), 1257–1262.
9. 9 Saggar, R, Khanna, D, Shapiro, S, et al. Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study. Arthritis Rheum 64:12 (2012), 4072–4077.
10. 10 Kovacs, G, Maier, R, Aberer, E, et al. Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. Chest 138:2 (2010), 270–278.
11. 11 Kovacs, G, Olschewski, A, Berghold, A, Olschewski, H, Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J 39:2 (2012), 319–328.
12. 12 Simonneau, G, Gatzoulis, MA, Adatia, I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:suppl 25 (2013), D34D–41.
13. 13 Hamada, K, Nagai, S, Tanaka, S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131:3 (2007), 650–656.
14. 14 Kessler, R, Faller, M, Fourgaut, G, Mennecier, B, Weitzenblum, E, Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1 (1999), 158–164.
15. 15 Bursi, F, McNallan, SM, Redfield, MM, et al. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol 59:3 (2012), 222–231.
16. 16 Naeije, R, Vanderpool, R, Dhakal, BP, et al. Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 187:6 (2013), 576–583.
17. 17 Janicki, JS, Weber, KT, Likoff, MJ, Fishman, AP, The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease. Circulation 72:6 (1985), 1270–1278.
18. 18 Argiento, P, Vanderpool, RR, Mulè, M, et al. Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest 142:5 (2012), 1158–1165.
19. 19 Lewis, GD, Murphy, RM, Shah, RV, et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 4:3 (2011), 276–285.